Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non–small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study

Autor: Cortot, Alexis B., Audigier-Valette, Clarisse, Molinier, Olivier, Le Moulec, Sylvestre, Barlesi, Fabrice, Zalcman, Gérard, Dumont, Patrick, Pouessel, Damien, Poulet, Claire, Fontaine-Delaruelle, Clara, Hiret, Sandrine, Dixmier, Adrien, Renault, Patrick-Aldo, Becht, Catherine, Raffy, Olivier, Dayen, Charles, Mazieres, Julien, Pichon, Eric, Langlais, Alexandra, Morin, Franck, Moro-Sibilot, Denis, Besse, Benjamin
Zdroj: In European Journal of Cancer May 2020 131:27-36
Databáze: ScienceDirect
Externí odkaz: